Maisons Lafitte, France

Jean-Jacques Koenig


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jean-Jacques Koenig: A Pioneer in 14-Aminosteroid Compounds

Introduction: Jean-Jacques Koenig, an inventor residing in Maisons Lafitte, France, has made significant contributions to the field of medicinal chemistry. With two registered patents to his name, Koenig focuses on the development of innovative compounds that have the potential to improve treatment options for various health conditions.

Latest Patents: Among his noteworthy inventions are the patents for deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds. The first patent describes a method for synthesizing these complex structures, specifically detailing a process that involves the addition of 6-deoxy-alpha-L-mannopyranosyl bromide and various solvents, heated in a controlled environment. This innovative compound structure has applications in treating individuals suffering from congestive heart failure. The second patent also elaborates on these 14-aminosteroid compounds, focusing on their pharmacological importance and utility in medical treatments.

Career Highlights: Koenig’s professional journey includes significant roles at prominent companies such as Procter & Gamble and Procter & Gamble Pharmaceuticals, Inc. His work in these organizations has allowed him to apply his inventive talents to the development of pharmaceutical products that can positively affect patients' lives.

Collaborations: Throughout his career, Koenig has had the opportunity to work alongside esteemed colleagues such as Song Liu and David Edward Portlock. Their collective expertise in the pharmaceutical field has contributed to the successful advancement of his innovative ideas and technologies.

Conclusion: Jean-Jacques Koenig stands out as a significant figure in the realm of medicinal innovations. With his pioneering patents for 14-aminosteroid compounds, he demonstrates a commitment to enhancing therapeutic tools for patients with congestive heart failure. His collaborative efforts and experience in reputable companies underscore the impact of his work in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…